Delivery Order SPE2DB20D1100-SPE2DB25FD6S2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,949.40 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $36,483.26. This firm fixed-price delivery order, which is not set-aside for any special contracting category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drops in a 3 milliliter unit, with a ceiling value of $14,043.34 and an ultimate completion date of September 11, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,297.46 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Miebo 100% eye drop (3ml units). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by June 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Miebo 100% eye drops (3 mL), with a ceiling value of $18,826.55. The contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,536.60 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed price, non-set-aside contract awarded through open competition. The award represents a small-value delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $6,769.00 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on June 16, 2025, with a completion date of June 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.18 to AmerisourceBergen Drug Corp for the supply of MIEBO 100% eye drops (3mL units) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,228.97 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drops (3mL) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6S2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Miebo 100% eye drops in 3ml units, valued at $8,033.24. This firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled for completion by July 29, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's SPE2DX prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for ophthalmic medication represents one of numerous transaction orders fulfilled through this expansive contract vehicle that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 7/28/25 |